NCT07341737 2026-01-15
SL-28 for Advanced Solid Tumours
Second Life Therapeutics
Phase 1/2 Not yet recruiting
Second Life Therapeutics
Beijing Pearl Biotechnology Limited Liability Company
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
University Medical Center Groningen